Pharmacological and Lifestyle Interventions for Female Fertility

Primary Recommendations

The American College of Obstetricians and Gynecologists recommends clomiphene citrate as first-line pharmacological treatment for women with polycystic ovary syndrome (PCOS) or ovulatory disorders attempting to conceive, with approximately 80% of PCOS patients ovulating and half of those who ovulate conceiving 1, 2, 3
Letrozole produces superior pregnancy outcomes compared to clomiphene, with higher ovulation rates, higher pregnancy rates, shorter time to conception, and more monofollicular development 2

Implement weight loss and exercise as the foundational treatment before any pharmacological intervention, targeting a 5% reduction in initial body weight through a 500-750 kcal/day energy deficit 1, 3
Exercise programs show positive effects independent of weight loss, with recommendations for at least 250 minutes/week of moderate-intensity activity for weight loss 3

Metformin improves insulin sensitivity, reduces ovarian androgen production, and improves ovulation frequency, and should be added when insulin resistance or glucose intolerance is documented 1, 3
Low-dose gonadotropin therapy is recommended if clomiphene or letrozole treatment fails, due to lower risk of ovarian hyperstimulation compared to standard doses 3
Pulsatile GnRH therapy shows 75-80% ovulation rates and 63-70% pregnancy rates per patient for functional hypothalamic amenorrhea with PCOM 4

Women with PCOS require closer monitoring throughout pregnancy, including regular blood pressure monitoring, kidney function assessment, and proteinuria screening 1
Prescribe low-dose aspirin from week 12 to week 36 to reduce preeclampsia risk 1

Screen for metabolic abnormalities: fasting glucose, 2-hour glucose tolerance test, and lipid profile 1, 3